ResearcherUniversity of Science and Technology of ChinaActive in the last 2 years
Shuai Ming
Matched on ORCID iD 0000-0003-0016-7209; OpenAlex author ID A5028889564. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2024: 1 paper · 2025: 1 paper · 2026: 6 papers
Papers 8
- Deciphering MFAP5+ Fibroblasts in Pancreatic Cancer Progression via Multi-Regional Single-Cell RNA Sequencing With Experimental Validation. Co-author DOI 10.1002/mc.70114↗
- Noninvasive Prediction of Tumor Malignancy Grade in Pancreatic Ductal Adenocarcinoma with Dual-Layer Detector CT: A Novel Index Integrating Histopathological D… Co-author DOI 10.1016/j.acra.2026.01.044↗
- Deep learning CT signature for predicting early liver metastases in pancreatic ductal adenocarcinoma Co-author DOI 10.1038/s41467-026-77665-z↗
- Model construction and validation of dual-energy CT multi-parameters combined with clinical indicators for predicting lymph node metastasis in pancreatic ducta… First author DOI 10.1186/s12880-026-02765-7↗
- Dual-energy CT extracellular volume fraction for predicting the chemotherapeutic response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40644-026-01110-z↗
- A MyCAF-Based Signature for Prognosis, Immune Landscape, and Therapeutic Response in Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-8878509/v1↗
- Contrast-enhanced CT-Derived extracellular volume fraction predicts survival in postoperative pancreatic cancer patients. Co-author DOI 10.1016/j.ejrad.2025.112273↗
- Recent advances in sonodynamic therapy strategies for pancreatic cancer. First author DOI 10.1002/wnan.1945↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dan Shi · 4 shared papers, 2026 · strength 1.11
- Paper Noninvasive Prediction of Tumor Malignancy Grade in Pancreatic Ductal Adenocarcinoma with Dual-Layer Detector CT: A Nov… DOI 10.1016/j.acra.2026.01.044↗
- Paper Deciphering MFAP5+ Fibroblasts in Pancreatic Cancer Progression via Multi-Regional Single-Cell RNA Sequencing With Expe… DOI 10.1002/mc.70114↗
- Paper A MyCAF-Based Signature for Prognosis, Immune Landscape, and Therapeutic Response in Pancreatic Cancer DOI 10.21203/rs.3.rs-8878509/v1↗
- Hongji Zhu · 3 shared papers, 2026 · strength 0.82
- Paper Model construction and validation of dual-energy CT multi-parameters combined with clinical indicators for predicting l… DOI 10.1186/s12880-026-02765-7↗
- Paper A MyCAF-Based Signature for Prognosis, Immune Landscape, and Therapeutic Response in Pancreatic Cancer DOI 10.21203/rs.3.rs-8878509/v1↗
- Paper Dual-energy CT extracellular volume fraction for predicting the chemotherapeutic response in pancreatic ductal adenocar… DOI 10.1186/s40644-026-01110-z↗
- Wei Wei · 2 shared papers, 2026 · strength 0.47
- Ben Zhao · 2 shared papers, 2026 · strength 0.46
- Mengru Li · 1 shared paper, 2026 · strength 0.30
- Wei Wei · 1 shared paper, 2026 · strength 0.30
- Wei Wei · 1 shared paper, 2026 · strength 0.29
- Wei Wei · 1 shared paper, 2026 · strength 0.28
- Bin Wang · 1 shared paper, 2026 · strength 0.28
- J J Li · 1 shared paper, 2026 · strength 0.28
- Wei Wei · 1 shared paper, 2026 · strength 0.26
- Wei Cao · 1 shared paper, 2024 · strength 0.24
- Wei Wei · 1 shared paper, 2024 · strength 0.24
- Peng Cheng · 1 shared paper, 2024 · strength 0.24
- Wei Wei · 1 shared paper, 2025 · strength 0.24
- Chenglin Zhu · 1 shared paper, 2025 · strength 0.24
- Qi Zhang · 1 shared paper, 2026 · strength 0.20
- Liwen Zhu · 1 shared paper, 2026 · strength 0.20
- Shenghong Ju 居胜红 · 1 shared paper, 2026 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.